CHA AI Healthkare Reduces Convertible Bond Issuance to 2.5 Billion Won with Zero Coupon and 1% Maturity Yield, Limited Dilution at 1.1% of Shares
CHA AI Healthkare initially decided to issue 5 billion won in convertible bonds on March 27, 2025, but after over a year of payment date changes and contract amendments, it finally reduced the issuance amount to 2.5005 billion won, changed the coupon rate from 5% to 0% and the maturity rate from 9% to 1%.
The conversion price is set at 12,463 won, approximately 91% above the current stock price of 6,530 won, and the bonds are issued via private placement with a 1-year conversion lock, exclusively allocated to Chacares. The proceeds are intended for investment funds, to be fully used in 2026.
Combined with the existing 40 billion won 36th CB, total potential convertible shares reach 4,708,183, representing 25.86% of outstanding shares, creating long-term overhang concerns. However, the new CB's conversion price premium minimizes immediate dilution risk.
The company has limited the call option exercise by the largest shareholder and related parties to their current shareholding ratio, partially mitigating governance risks.
[AI Summary]The reduction in CB size and lower interest rates ease funding costs, but the large potential dilution from the existing 40 billion won CB and the new issuance overhang may pressure long-term stock performance. The vague use of proceeds suggests a focus on financial stability rather than growth.
KOSPI Filing Information
[Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)